ATHENS -- The European Union is struggling to secure COVID-19 vaccines for itself, as well as offer them to foreign countries, while China is exerting its influence by supplying jabs to emerging economies.
Although state-owned Sinopharm and other Chinese makers of COVID vaccines have not applied to the European Medicine Agency for licenses to distribute their shots, they are finding their way into European arms. Many experts, however, have expressed concern over a lack of transparency in China's clinical trials, fueling debate over the wisdom of accepting the supplies.
%2520%E3%81%AE%E3%82%B3%E3%83%92%E3%82%9A%E3%83%BC%E3%81%AE%E3%82%B3%E3%83%92%E3%82%9A%E3%83%BC.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
